HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Danielle Derocq Selected Research

Drug Therapy (Chemotherapy)

1/2019Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Danielle Derocq Research Topics

Disease

8Breast Neoplasms (Breast Cancer)
01/2019 - 08/2002
7Neoplasms (Cancer)
01/2021 - 08/2002
4Neoplasm Metastasis (Metastasis)
09/2015 - 08/2002
2Triple Negative Breast Neoplasms
01/2021 - 01/2019
2Carcinogenesis
09/2015 - 08/2002

Drug/Important Bio-Agent (IBA)

9Peptide Hydrolases (Proteases)FDA Link
01/2021 - 08/2002
9Cathepsin DIBA
01/2021 - 08/2002
1AntibodiesIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1Parathyroid Hormone-Related ProteinIBA
09/2015
1Indicators and Reagents (Reagents)IBA
12/2012
1CathepsinsIBA
12/2012
1Cysteine (L-Cysteine)FDA Link
12/2012
1procathepsin DIBA
12/2012
1Cystatin CIBA
12/2012
1EnzymesIBA
11/2010
1Carrier Proteins (Binding Protein)IBA
11/2010
1Cell Surface ReceptorsIBA
06/2006
1Complementary DNA (cDNA)IBA
08/2002
1matrigelIBA
08/2002
1AgarIBA
08/2002

Therapy/Procedure

3Therapeutics
01/2021 - 08/2002
1Immunotherapy
01/2019
1Drug Therapy (Chemotherapy)
01/2019
1Adjuvant Chemotherapy
01/2019